Table 1 Clinical, laboratory, and HIV-infection characteristics in patients with CKD and without it

Age (years) median/IQR

30 (26–36)

34 (31–44)

-

0.028

Age > 30 years (n/%)

37 (50)

16 (84)

3.9 (1.2–13)

0.008

Gender

 Female (n/%)

4 (6)

1 (5.5)

0.87 (0.14–5.3)

ns

 Male (n/%)

69 (94)

18 (94.5)

0.88 (0.14–5.4)

ns

Tobacco (n/%)

42 (57)

13 (68)

1.5 (0.61–3.5)

ns

Drugs (n/%)

41 (56)

11 (59)

1.1 (0.47–2.4)

ns

Alcohol (n/%)

56 (77)

15 (78)

1.1 (0.41–3)

ns

Type 2 Diabetes Mellitus (n/%)

3 (4.1)

0

-

-

Arterial hypertension

0

1 (5.2)

-

-

HIV-1 Viral Load (cop/mL)

Median/IQR

52,000

(24,650–111,000)

169,000

(73,700–453,847)

-

0.001

Viral Load HIV-1 (≥ 100,000 cop/mL)

24 (32)

12 (63)

2.7 (1.2–6.1)

0.019

CD4⁺ T cells count (cells/μL)

Median/IQR

323 (161–552)

163 (58–300)

-

0.003

CD4⁺ T cells < 200 cells/μL (n/%)

32 (43)

15 (79)

4 (1.2–13)

0.007

CD4/CD8 ratio (median/IQR)

0.30 (0.14–0.51)

0.20 (0.09–0.33)

-

0.022

Clinical stage at baseline:

 Stage A

43 (58.9)

7 (36)

0.56 (0.24–1.3)

ns

 Stage B

20 (27.4)

3 (15.7)

0.56 (0.18–1.8)

ns

 Stage C

10 (13.7)

9 (47.3)

3.5 (1.9–7.3)

0.002

Coinfections

 Hepatitis B virus

2 (2.7)

0

-

-

 Hepatitis C virus

2 (2.7)

4 (21)

3.8 (1.8–7.9)

0.015

 M. tuberculosis

2 (2.7)

5 (26)

4.3 (2.2–8.5)

0.003

 Syphilis (VDRL +)

23 (32)

5 (26)

0.82 (0.33–2)

ns